Canaccord Genuity Maintains a 'Buy' on Anthera Pharma (ANTH); Hard Stop to Varespledib/A001 Development
Tweet
Share
E-mailGet Alerts ANTH Hot Sheet
Price: $0.00 --0%
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Anthera Pharma (NASDAQ: ANTH) price target cut from $13 to $6.
Analyst, Ritu Baral, said, "Maintain rating, lowering target after varespledib development stop on DSMB recommendation. We still expect blisibimod, ANTH’s Phase 2/3 BAFF peptibody for lupus, will yield positive data from the PEARL-SC trial in June. We also expect ANTH to start Phase 2 blisibimod trials in other B-cell disorders related to lupus to leverage market potential and diversify clinical risk. We lowered our pNPV-based target to $6 after removing varespledib from our valuation."
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
Shares of Anthera Pharma closed at $6.42 yesterday.
Analyst, Ritu Baral, said, "Maintain rating, lowering target after varespledib development stop on DSMB recommendation. We still expect blisibimod, ANTH’s Phase 2/3 BAFF peptibody for lupus, will yield positive data from the PEARL-SC trial in June. We also expect ANTH to start Phase 2 blisibimod trials in other B-cell disorders related to lupus to leverage market potential and diversify clinical risk. We lowered our pNPV-based target to $6 after removing varespledib from our valuation."
For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.
Shares of Anthera Pharma closed at $6.42 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Palmer Square Capital BDC (PSBD) PT Lowered to $10.25 at BofA Securities
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
